BioVaxys Technology (TSE:BIOV) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
BioVaxys Technology Corp. has successfully closed the second tranche of its non-brokered private placement, raising $175,000 by issuing 3.5 million units at $0.05 per unit. The funds will be used to boost the company’s working capital, with each unit comprising one common share and a warrant convertible at $0.15 by December 2026.
For further insights into TSE:BIOV stock, check out TipRanks’ Stock Analysis page.